Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Halozyme Therapeutics Inc...

    NASDAQ: HALO · Real-Time Price · USD
    67.07
    1.53 (2.33%)
    At close: Aug 15, 2025, 1:20 PM

    Halozyme Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 444.09M 281.59M 202.13M 402.71M
    Depreciation & Amortization
    		 81.31M 84.86M 49.64M 3M
    Stock-Based Compensation
    		 43.38M 36.62M 24.4M 20.82M
    Other Working Capital
    		 5.36M 4.1M -9.06M -11.55M
    Other Non-Cash Items
    		 -979K -10.33M 9.89M 24.61M
    Deferred Income Tax
    		 532K 34.51M 40.01M -155.43M
    Change in Working Capital
    		 -89.28M -38.67M -85.95M 3.74M
    Operating Cash Flow
    		 479.06M 388.57M 240.11M 299.44M
    Capital Expenditures
    		 -10.7M -15.29M -4.81M -1.46M
    Cash Acquisitions
    		 n/a n/a -999.12M 404.83M
    Purchase of Investments
    		 -647.6M -292.91M -255.21M -652.51M
    Sales Maturities Of Investments
    		 395.57M 211.3M 746.13M 247.68M
    Other Investing Acitivies
    		 n/a n/a 26.01M -404.83M
    Investing Cash Flow
    		 -262.72M -96.91M -487M -406.29M
    Debt Repayment
    		 n/a -13.48M 624.55M 415.81M
    Common Stock Repurchased
    		 -250M -402.38M -200M -350.06M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 31.14M 7.88M -62.17M 12.11M
    Financial Cash Flow
    		 -218.86M -407.99M 362.37M 77.86M
    Net Cash Flow
    		 -2.52M -116.33M 115.48M -28.98M
    Free Cash Flow
    		 468.37M 373.28M 235.3M 297.98M

    Add to Watchlist